Moreover, at least one study has demonstrated that inhibition of ERK signalling in pancreatic cancer cell lines leads to downregulation of Bcl-2 and other antiapoptotic proteins, including MCL-1 (Boucher et al, 2000). This evidence concerns the gene MCL1 and familial pancreatic carcinoma.